Literature DB >> 31127860

Real-world effectiveness and safety of dupilumab for the treatment of atopic dermatitis in Japanese patients: a single-centre retrospective study.

H Uchida1, M Kamata1, I Mizukawa1, A Watanabe1, A Agematsu1, M Nagata1, S Fukaya1, K Hayashi1, A Fukuyasu1, T Tanaka1, T Ishikawa1, T Ohnishi1, Y Tada1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31127860     DOI： 10.1111/bjd.18163

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  6 in total

1.  Rapid Enlargement of Vitiligo Vulgaris after Initiation of Dupilumab for Atopic Dermatitis: A Case Report.

Authors:  Shintaro Takeoka; Masahiro Kamata; Ikumi Yokoi; Aya Takehara; Yayoi Tada
Journal:  Acta Derm Venereol       Date:  2021-10-28       Impact factor: 3.875

Review 2.  Therapeutic New Era for Atopic Dermatitis: Part 1. Biologics.

Authors:  Jiyoung Ahn; Yusung Choi; Eric Lawrence Simpson
Journal:  Ann Dermatol       Date:  2020-12-30       Impact factor: 1.444

Review 3.  A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis.

Authors:  Masahiro Kamata; Yayoi Tada
Journal:  JID Innov       Date:  2021-07-30

4.  Efficacy and Safety of Dupilumab in Chinese Patients With Atopic Dermatitis: A Real-World Study.

Authors:  Bingjing Zhou; Cong Peng; Liqiao Li; Runqiu Liu; Lei Zhu; Xiang Chen; Jie Li
Journal:  Front Med (Lausanne)       Date:  2022-03-23

Review 5.  Atopic Dermatitis: Identification and Management of Complicating Factors.

Authors:  Risa Tamagawa-Mineoka; Norito Katoh
Journal:  Int J Mol Sci       Date:  2020-04-11       Impact factor: 5.923

Review 6.  New and Emerging Systemic Treatments for Atopic Dermatitis.

Authors:  Megan Newsom; Arjun M Bashyam; Esther A Balogh; Steven R Feldman; Lindsay C Strowd
Journal:  Drugs       Date:  2020-07       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.